Co-Diagnostics (CODX) Set to Announce Earnings on Thursday

Co-Diagnostics (NASDAQ:CODX) is scheduled to release its earnings data after the market closes on Thursday, May 9th. Analysts expect Co-Diagnostics to post earnings of ($0.21) per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.

Co-Diagnostics (NASDAQ:CODX) last issued its quarterly earnings results on Thursday, March 14th. The company reported ($0.50) earnings per share (EPS) for the quarter. The business had revenue of $3.56 million for the quarter, compared to the consensus estimate of $3.63 million. Co-Diagnostics had a negative net margin of 518.69% and a negative return on equity of 35.37%.

Co-Diagnostics Stock Performance

Shares of CODX opened at $1.26 on Wednesday. The company has a market cap of $39.39 million, a PE ratio of -1.04 and a beta of -0.65. The stock has a 50-day moving average price of $1.16 and a 200-day moving average price of $1.20. Co-Diagnostics has a 12-month low of $0.98 and a 12-month high of $1.89.

Wall Street Analyst Weigh In

Separately, HC Wainwright decreased their price objective on Co-Diagnostics from $3.00 to $2.50 and set a “neutral” rating on the stock in a report on Friday, March 15th.

Co-Diagnostics Company Profile

Co-Diagnostics, Inc, a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting.